Literature DB >> 1167349

Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression.

R A Tobey, H A Crissman.   

Abstract

Three nitrosourea analogs, 1,3-bis(2-chloroethyl)-1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, and 1-trans-(2-chloroethyl)-3-cyclohexyl-1-(4-methylcyclohexyl)-1-nitrosourea, were examined for effects on survival and cell cycle traverse capacity in exponentially growing (cycling) populations of line CHO Chinese hamster cells and in cultures arrested in G1 by isoleucine deprivation during treatment with drugs, then returned to the cycling mode by restoration of isoleucine (noncycling cells). Among parameters studied were survival, cell division, DNA initiation capacities, cell cycle distributions, and rates of cell cycle traverse in drug-treated cycling and noncycling cells utilizing a protocol combining autoradiography, cell number enumeration, and flow microfluorometry. The results obtained were in generally good agreement with results obtained in vivo in other studies and included the following. Cells treated with any of these agents accumulated preferentially in late S and G2, primarily the result of a gross increase in duration of these phases of the cell cycle. There was also a prolongation of doubling time during the early stages following drug treatment and return to the proliferating mode of cells which ultimately survived. All three drugs induced mitotic nondisjunction in cells capable of dividing and also induced polyploidy by allowing multiple rounds of progression through the cell cycle in the absence of an intervening cell division. In treated populations, the G2-arrested and polyploid cells were among the first cells to die. Treated, noncycling cells that were returned to cycle exhibited a lower survival capacity than did treated, cycling cells. Finally, 1-(2-chloroethyl-3-cyclohexyl)-1-nitrosourea and 1-trans(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea induced a dramatic alteration in clonal morphology and growth patterns in surviving cells that persisted for at least a week after drug removal. The results obtained suggest that our model system may be useful as a predictive guide for determining response of susceptible tumor cells to treatment with chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167349

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models.

Authors:  Kader Yagiz; Tiffany T Huang; Fernando Lopez Espinoza; Daniel Mendoza; Carlos E Ibañez; Harry E Gruber; Douglas J Jolly; Joan M Robbins
Journal:  Neuro Oncol       Date:  2016-05-10       Impact factor: 12.300

Review 2.  The molecular basis of drug-induced G2 arrest in mammalian cells.

Authors:  P N Rao
Journal:  Mol Cell Biochem       Date:  1980-01-16       Impact factor: 3.396

3.  Synchronization of 9L rat brain tumor cells by centrifugal elutriation.

Authors:  P C Keng; C K Li; K T Wheeler
Journal:  Cell Biophys       Date:  1980-09

Review 4.  Selective uptake and retention of anticancer agents by sensitive cells.

Authors:  D L Hill; J A Montgomery
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  The effects of 1-methyl-1-nitrosourea on the survival pattern of cycling and noncycling HeLa cells.

Authors:  J Ban; B Brdar; J Sorić
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

6.  Responses of proliferating and non-proliferating Chinese hamster cells to cytotoxic agents.

Authors:  O I Epifanova; I N Smolenskaya; V A Polunovsky
Journal:  Br J Cancer       Date:  1978-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.